Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1986 1
1987 6
1988 3
1989 2
1990 1
1991 4
1992 6
1993 3
1994 7
1995 2
1996 4
1997 3
1998 2
1999 2
2000 3
2001 1
2002 3
2003 3
2004 1
2006 1
2007 3
2008 4
2009 8
2010 10
2011 6
2012 15
2013 10
2014 3
2015 7
2016 15
2017 21
2018 16
2019 8
2020 13
2021 13
2022 10
2023 3
Text availability
Article attribute
Article type
Publication date

Search Results

192 results
Results by year
Filters applied: . Clear all
Page 1
Epidemiology of Parkinson's disease.
Tysnes OB, Storstein A. Tysnes OB, et al. J Neural Transm (Vienna). 2017 Aug;124(8):901-905. doi: 10.1007/s00702-017-1686-y. Epub 2017 Feb 1. J Neural Transm (Vienna). 2017. PMID: 28150045 Review.
The NADPARK study: A randomized phase I trial of nicotinamide riboside supplementation in Parkinson's disease.
Brakedal B, Dölle C, Riemer F, Ma Y, Nido GS, Skeie GO, Craven AR, Schwarzlmüller T, Brekke N, Diab J, Sverkeli L, Skjeie V, Varhaug K, Tysnes OB, Peng S, Haugarvoll K, Ziegler M, Grüner R, Eidelberg D, Tzoulis C. Brakedal B, et al. Among authors: tysnes ob. Cell Metab. 2022 Mar 1;34(3):396-407.e6. doi: 10.1016/j.cmet.2022.02.001. Cell Metab. 2022. PMID: 35235774 Free article. Clinical Trial.
Genome-wide survival study identifies a novel synaptic locus and polygenic score for cognitive progression in Parkinson's disease.
Liu G, Peng J, Liao Z, Locascio JJ, Corvol JC, Zhu F, Dong X, Maple-Grødem J, Campbell MC, Elbaz A, Lesage S, Brice A, Mangone G, Growdon JH, Hung AY, Schwarzschild MA, Hayes MT, Wills AM, Herrington TM, Ravina B, Shoulson I, Taba P, Kõks S, Beach TG, Cormier-Dequaire F, Alves G, Tysnes OB, Perlmutter JS, Heutink P, Amr SS, van Hilten JJ, Kasten M, Mollenhauer B, Trenkwalder C, Klein C, Barker RA, Williams-Gray CH, Marinus J; International Genetics of Parkinson Disease Progression (IGPP) Consortium; Scherzer CR. Liu G, et al. Among authors: tysnes ob. Nat Genet. 2021 Jun;53(6):787-793. doi: 10.1038/s41588-021-00847-6. Epub 2021 May 6. Nat Genet. 2021. PMID: 33958783 Free PMC article.
Re: Utredning ved mistenkt kronisk utmattelsessyndrom.
Tysnes OB, Næss H, Owe J. Tysnes OB, et al. Tidsskr Nor Laegeforen. 2016 Jun 7;136(10):892. doi: 10.4045/tidsskr.16.0409. eCollection 2016 Jun. Tidsskr Nor Laegeforen. 2016. PMID: 27272355 Free article. Norwegian. No abstract available.
Validation of a UPDRS-/MDS-UPDRS-based definition of functional dependency for Parkinson's disease.
Ramsay N, Macleod AD, Alves G, Camacho M, Forsgren L, Lawson RA, Maple-Grødem J, Tysnes OB, Williams-Gray CH, Yarnall AJ, Counsell CE; Parkinson's Incidence Cohorts Collaboration; PINE Study; CamPaIGN study; PICNICS study; NYPUM Study; ParkWest Study: ParkWest Principal investigators; Study personnel; ICICLE-PD Study. Ramsay N, et al. Among authors: tysnes ob. Parkinsonism Relat Disord. 2020 Jul;76:49-53. doi: 10.1016/j.parkreldis.2020.05.034. Epub 2020 May 30. Parkinsonism Relat Disord. 2020. PMID: 32645619
GBA and APOE Impact Cognitive Decline in Parkinson's Disease: A 10-Year Population-Based Study.
Szwedo AA, Dalen I, Pedersen KF, Camacho M, Bäckström D, Forsgren L, Tzoulis C, Winder-Rhodes S, Hudson G, Liu G, Scherzer CR, Lawson RA, Yarnall AJ, Williams-Gray CH, Macleod AD, Counsell CE, Tysnes OB, Alves G, Maple-Grødem J; Parkinson's Incidence Cohorts Collaboration. Szwedo AA, et al. Among authors: tysnes ob. Mov Disord. 2022 May;37(5):1016-1027. doi: 10.1002/mds.28932. Epub 2022 Feb 2. Mov Disord. 2022. PMID: 35106798 Free PMC article.
[Atypical parkinsonism].
Tysnes OB, Vilming ST. Tysnes OB, et al. Tidsskr Nor Laegeforen. 2008 Sep 25;128(18):2077-80. Tidsskr Nor Laegeforen. 2008. PMID: 18846125 Free article. Review. Norwegian.
July 2017 ENCALS statement on edaravone.
Al-Chalabi A, Andersen PM, Chandran S, Chio A, Corcia P, Couratier P, Danielsson O, de Carvalho M, Desnuelle C, Grehl T, Grosskreutz J, Holmøy T, Ingre C, Karlsborg M, Kleveland G, Koch JC, Koritnik B, KuzmaKozakiewicz M, Laaksovirta H, Ludolph A, McDermott C, Meyer T, Mitre Ropero B, Mora Pardina J, Nygren I, Petri S, Povedano Panades M, Salachas F, Shaw P, Silani V, Staaf G, Svenstrup K, Talbot K, Tysnes OB, Van Damme P, van der Kooi A, Weber M, Weydt P, Wolf J, Hardiman O, van den Berg LH. Al-Chalabi A, et al. Among authors: tysnes ob. Amyotroph Lateral Scler Frontotemporal Degener. 2017 Nov;18(7-8):471-474. doi: 10.1080/21678421.2017.1369125. Epub 2017 Oct 4. Amyotroph Lateral Scler Frontotemporal Degener. 2017. PMID: 28975816 Free article. Review. No abstract available.
Parkinson's disease clinical milestones and mortality.
Gonzalez MC, Dalen I, Maple-Grødem J, Tysnes OB, Alves G. Gonzalez MC, et al. Among authors: tysnes ob. NPJ Parkinsons Dis. 2022 May 12;8(1):58. doi: 10.1038/s41531-022-00320-z. NPJ Parkinsons Dis. 2022. PMID: 35550520 Free PMC article.
[Dementia in Parkinson's disease].
Halvorsen Ø, Tysnes OB. Halvorsen Ø, et al. Among authors: tysnes ob. Tidsskr Nor Laegeforen. 2007 Oct 4;127(19):2517-20. Tidsskr Nor Laegeforen. 2007. PMID: 17925819 Free article. Review. Norwegian.
192 results